Faculty profile

Eric Asselin

ResearcherBiologie médicaleUniversité du Québec à Trois-Rivières

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université du Québec à Trois-Rivières directory, so their courses and email address may be missing. Find their university profile.

Eric Asselin

Researcher

Biologie médicale

Université du Québec à Trois-Rivières

Trois-Rivières, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2018.
Principal investigator on 11 research grants (7 NSERC, 4 CIHR), most recently in 2019.
Supervisor on 7 trainee awards (7 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Akt Apoptosis Cell signaling Cell survival Estrogen Uterus

Latest papers

PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways.
Molecular cancer research : MCR · 2018
Exploring the synthesis and anticancer potential of L-tyrosine-platinum(II) hybrid molecules.
Medicinal chemistry (Shariqah (United Arab Emirates)) · 2015
Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors.
The Journal of endocrinology · 2011 · senior author

All 8 publications

Latest funding

The role and regulation of cell survival in uterine functions.
NSERC · 2019 · Principal investigator
$300,000
Regulation of cell survival in the pregnant rat endometrium.
NSERC · 2013 · Principal investigator
$165,000
Signalisation Québec 2014
CIHR · 2013 · Co-investigator
$25,000

All 22 grants and awards

8 publications.

PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways.

Zhao Y, Montminy T, Azad T, Lightbody E, Hao Y, SenGupta S, Asselin E, Nicol C, Yang X

Molecular cancer research : MCR2018

DOI: 10.1158/1541-7786.mcr-17-0593 PMID: 29545474

Exploring the synthesis and anticancer potential of L-tyrosine-platinum(II) hybrid molecules.

Descôteaux C, Brasseur K, Leblanc V, Asselin E, Bérubé G

Medicinal chemistry (Shariqah (United Arab Emirates))2015

DOI: 10.2174/1573406411666150504123750 PMID: 25938424

Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors.

Singh M, Chaudhry P, Asselin E

The Journal of endocrinology2011Senior author

DOI: 10.1530/joe-10-0461 PMID: 21372150

XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling.

Van Themsche C, Chaudhry P, Leblanc V, Parent S, Asselin E

Molecular cancer2010Senior author

DOI: 10.1186/1476-4598-9-216 PMID: 20712893

Akt isoforms regulate intermediate filament protein levels in epithelial carcinoma cells.

Fortier AM, Van Themsche C, Asselin E, Cadrin M

FEBS letters2010

DOI: 10.1016/j.febslet.2010.01.045 PMID: 20109457

Resistance to chemotherapy and hormone therapy in endometrial cancer.

Chaudhry P, Asselin E

Endocrine-related cancer2009Senior author

DOI: 10.1677/erc-08-0266 PMID: 19190080

Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.

Gagnon V, Van Themsche C, Turner S, Leblanc V, Asselin E

Apoptosis : an international journal on programmed cell death2008Senior author

DOI: 10.1007/s10495-007-0165-6 PMID: 18071906

Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.

Leblanc K, Sexton E, Parent S, Bélanger G, Déry MC, Boucher V, Asselin E

International journal of oncology2007Senior author

PMID: 17203231

The role and regulation of cell survival in uterine functions.

Principal investigatorNSERC2019Discovery Grants Program - Individual

Principal investigators: Asselin, Eric

Keywords: cell signaling; uterus; cell survival; apoptosis; estrogen; akt

$300,000

Regulation of cell survival in the pregnant rat endometrium.

Principal investigatorNSERC2013Discovery Grants Program - Individual

Principal investigators: Asselin, Eric

$165,000

Signalisation Québec 2014

Co-investigatorCIHR2013Dissemination Events - Priority Announcement: Cancer Research

Principal investigators: Laprise, Patrick

Keywords: Biologie Du Cancer; Identification De Cibles Thérapeutiques En Oncologie; Signalisation Intracellulaire

$25,000

Impact de l'isoforme TGF beta1 et des mutations de p53 dans la signalisation cellulaire de lignées cancéreuses ovariennes en réponse au cisplatine.

SupervisorCIHR2012Master's Award: Canada Graduate Scholarships

Principal investigators: Baribeau, Sébastien

Keywords: Apoptose; Cancer Ovarien; Chimiorésistance; Chimiothérapie (Cisplatine); Culture Cellulaire; P53; Signalisation Cellulaire; Transforming Growth Factor Beta; Transition Épithéliale-Mésenchymale; Western Blot

$17,500

Chimiorésistance et mécanisme d'une nouvelle cible thérapeutique intracellulaire chez le cancer ovarien, PAR-4

SupervisorCIHR2012Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Brasseur, Kevin

Keywords: Apoptose; Cancer Ovarien; Chimiorésistance; Cible Thérapeutique; Cisplatine; Lentivirus; Oestrogène; Par-4; Xenogreffes; Électrophorèse

$105,000

L'étude d'un nouveau composé chimiothérapeutique hybride E2-Pt spécifique envers les cancers gynécologiques hormono-dépendants, le VP-128

SupervisorCIHR2011Master's Award: Canada Graduate Scholarships

Principal investigators: Brasseur, Kevin

Keywords: Apoptose; Cancers Gynécologiques; Chimiothérapie; Cible Thérapeutique; Immunobuvardage De Type Western; Micropuces Adn-Arn; Oestrogène; Rt-Pcr En Temps Réel; Survie Cellulaire; Xénogreffes

$17,500

CANADA RESEARCH CHAIRHOLDER / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA

Nominated PICIHR2011Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Asselin, Eric

Keywords: Chairs

$500,000

Vectorization of New Anticancer Agents to Target Prostate Cancer Cells via their Conjugation to Testosterone: Design, Synthesis and Biological Evaluation

SupervisorCIHR2011CIHR Fellowship

Principal investigators: Fortin, Sébastien

Keywords: Alkylating Agents; Antiandrogens; Anticancer Agents; Cancer Chemotherapy; Conjugation Testosterone-Drugs; Medicinal Chemistry; Molecular Cell Biology; Molecular Modeling; Molecular Pharmacology; Vectorization Cancer Therapy

$135,000

Vectorization of New Anticancer Agents to Target Prostate Cancer Cells via their Conjugation to Testosterone: Design, Synthesis and Biological Evaluation

SupervisorCIHR2011Fellowship: Jean-François St-Denis (Prize)

Principal investigators: Fortin, Sébastien

$15,000

Le chemin de survie cellulaire de PI3-K/Akt au niveau de l'endomètre de la rate gestante, pseudogestante et non-gestante.

SupervisorCIHR2010Master's Award: Canada Graduate Scholarships

Principal investigators: Lafleur, Marie-Judith

Keywords: Apoptose; Endomètre; Phénomène D'Implantation; Prolifération Cellulaire; Qrt-Pcr; Trophoblaste; Western Blot

$17,500

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Eric Asselin

Research

Latest papers

Latest funding

PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways.

Exploring the synthesis and anticancer potential of L-tyrosine-platinum(II) hybrid molecules.

Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors.

XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling.

Akt isoforms regulate intermediate filament protein levels in epithelial carcinoma cells.

Resistance to chemotherapy and hormone therapy in endometrial cancer.

Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.

Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.

The role and regulation of cell survival in uterine functions.

Regulation of cell survival in the pregnant rat endometrium.

Signalisation Québec 2014

Impact de l'isoforme TGF beta1 et des mutations de p53 dans la signalisation cellulaire de lignées cancéreuses ovariennes en réponse au cisplatine.

Chimiorésistance et mécanisme d'une nouvelle cible thérapeutique intracellulaire chez le cancer ovarien, PAR-4

L'étude d'un nouveau composé chimiothérapeutique hybride E2-Pt spécifique envers les cancers gynécologiques hormono-dépendants, le VP-128

CANADA RESEARCH CHAIRHOLDER / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA

Vectorization of New Anticancer Agents to Target Prostate Cancer Cells via their Conjugation to Testosterone: Design, Synthesis and Biological Evaluation

Vectorization of New Anticancer Agents to Target Prostate Cancer Cells via their Conjugation to Testosterone: Design, Synthesis and Biological Evaluation

Le chemin de survie cellulaire de PI3-K/Akt au niveau de l'endomètre de la rate gestante, pseudogestante et non-gestante.

Frequent collaborators

Monique Cadrin

Xiaolong Yang

Taha Azad